<http://schema.org/description>
"Celgene&amp;#39;s Otezla isn&amp;#39;t going to beat antiinflamatory drugs from AbbVie, Johnson &amp;amp; Johnson, and Amgen on efficacy, but the biotech can still find a niche for its new psoriatic arthritis drug."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2014/03/29/finding-a-niche-for-celgenes-otezla.aspx>